| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |